Foghorn Therapeutics Inc (FHTX)
8.92
+0.68
(+8.25%)
USD |
NASDAQ |
Nov 05, 16:00
8.92
0.00 (0.00%)
After-Hours: 18:30
Foghorn Therapeutics Shareholders Equity (Quarterly): -14.32M for June 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -14.32M |
| March 31, 2024 | -97.49M |
| December 31, 2023 | -77.19M |
| September 30, 2023 | -57.39M |
| June 30, 2023 | -49.35M |
| March 31, 2023 | -24.59M |
| December 31, 2022 | 0.112M |
| September 30, 2022 | 24.32M |
| June 30, 2022 | 47.63M |
| Date | Value |
|---|---|
| March 31, 2022 | 72.40M |
| December 31, 2021 | 96.87M |
| September 30, 2021 | 80.98M |
| June 30, 2021 | 104.19M |
| March 31, 2021 | 125.16M |
| December 31, 2020 | 146.19M |
| September 30, 2020 | -133.32M |
| June 30, 2020 | 18.11M |
| December 31, 2019 | -88.02M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-133.32M
Minimum
Sep 2020
146.19M
Maximum
Dec 2020
9.684M
Average
9.112M
Median
Shareholders Equity (Quarterly) Benchmarks
| Sana Biotechnology Inc | 339.65M |
| Omega Therapeutics Inc | 26.26M |
| Moderna Inc | 11.71B |
| Corcept Therapeutics Inc | 638.84M |
| Akebia Therapeutics Inc | -33.75M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 328.58M |
| Total Liabilities (Quarterly) | 342.91M |
| Current Ratio | 5.693 |